Tissue and organ transplantation is a medical procedure involving the transplantation, or transferring, of tissue(s) or organ(s) from a donor to a recipient. The transplanted tissue or organ replaces a damaged or absent tissue or organ. The global tissue and organ transplantation market involves various products and services including tissues such as skin, musculoskeletal tissues, cardiovascular tissues, and others as well eye and tissues required for transplantation. The market includes organ transplantation of heart, lungs, kidneys, liver, pancreas, intestine, and thymus gland. Increasing cases of organ failure worldwide due to factors such as hypertension, obesity, and diabetes is a major driver of the market. Further, rising cases of accidents and trauma have also contributed significantly to the increasing prevalence of organ failure diseases.

The global Tissue And Organ Transplantation Market is estimated to be valued at Us$ 20.8 Billion In 2023 and is expected to exhibit a CAGR Of 7.9% over the forecast period 2024 To 2031, as highlighted in a new report published by Coherent Market Insights.

Market Dynamics:

The global tissue and organ transplantation market is expected to driven by growing prevalence of organ failure diseases worldwide owing to increasing risk factors such as sedentary lifestyle, poor diets, substance abuse, and others. According to WHO, cardiovascular diseases are the number one causes of death globally, taking an estimated 17.9 million lives each year. Further, the market will also be significantly fuelled by shortage of organs donation, promoting increased research activities into stem cells and tissue engineering. This has led to novel tissue and organ regeneration techniques using 3D bioprinting and decellularized organs. Further, rising investment by key players and government agencies in R&D is also expected to augment the market growth over the forecast period. However, high cost of transplantation procedures and ethical issues related to organ donation may restrain the market to some extent.

Segment Analysis

The tissue and organ transplantation market is broadly segmented into tissue products and organ transplantation. Within tissue products, skin tissue is dominating the segment with around 35% market share owing to the high demand for skin tissue for burn patients and wounds. Skin tissue segment is followed by bone tissue segment which holds around 25% share due to rising musculoskeletal injuries and accidents.

PEST Analysis

Political: The market is driven by favorable government policies and focus on modernizing healthcare systems across countries. Various governments are working on establishing robust regulatory frameworks for organ transplantation to increase donors.

Economic: Rising healthcare spending and increasing focus on critical care is fueling the market growth. However, high costs associated with organ transplantation procedures can hamper the market.

Social: Growing public-private partnerships to promote organ donation and transplantation is a key trend. However, socio-cultural barriers still persist in some regions which impact the donation rates.

Technological: Advancements in tissue engineering, organ regeneration therapies, and focus on developing artificial organs are transforming the market. Technologies such as 3D bioprinting of tissues and organs holds promise.

Key Takeaways

The Global Tissue And Organ Transplantation Market Demand is expected to witness high growth at a CAGR of 7.9% during the forecast period of 2024 to 2031. The global tissue and organ transplantation Market is estimated to be valued at US$ 20.8 Billion in 2023 and is expected to exhibit a CAGR of 7.9% over the forecast period 2024 to 2031.

Regional analysis comprises North America dominates the market currently owing to rising cases of organ failure, established healthcare infrastructure, and presence of key players in the region. The Asia Pacific region is expected to be the fastest growing market in the coming years due to growing medical tourism, increasing healthcare spending, and favorable government policies promoting organ donation in countries like China and India.

Key players operating in the tissue and organ transplantation market are Probi AB, Chr. Hansen Holding A/S, Danone S.A., Yakult Honsha Co., Ltd., Nestle S.A., DowDuPont Inc., Kerry Group plc, BioGaia AB, Probiotics International Limited (Protexin), UAS Laboratories LLC. Key players are focusing on new product launches, collaborations and acquisitions to strengthen their market presence.

Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it